Novo Nordisk A Fs reported $456M in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Ani Pharmaceuticals ANIP:US $ 0M 0M
Aurora Cannabis Inc ACB:CN 6.57B 141.91M
Bristol Myers Squibb BMY:US $ 292M 0M
Canopy Growth Corp WEED:CN C$ 7.6B 118.76M
Catalent CTLT:US $ 2M 0M
Corcept Therapeutics CORT:US $ 0.13M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Endo International Ordinary Shares ENDP:US $ 0.07M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Horizon Pharma HZNP:US $ 0.02M 0M
JAZZ PHA JAZZ:US $ 0.06M 0M
Lannett LCI:US $ 0.04M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NOVN:VX SF 890M 11M
Novo Nordisk A Fs NVO:US $ 456M 6M
Pacira Pharmaceuticals PCRX:US $ 0.05M 0M
Perrigo Ordinary Shares PRGO:US $ 6991.1M 27.8M
Phibro Animal Health PAHC:US $ 0M 0M
Prestige Brands PBH:US $ 0.55M 0M
Supernus Pharmaceuticals SUPN:US $ 0.05M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
Valeant Pharmaceuticals VRX:CN $ 10373M 56M
Zoetis ZTS:US $ 5M 0M